UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Pharma News | Bristol Myers Squibb, Teva, MedinCell, Biogen
Teva Announces FDA Approval of ProAir RespiClick - Drug Discovery and Development
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults | Business Wire
Good news for Teva as FDA expedites novel-class migraine therapy
FDA Approves Teva's Generic Version of EpiPen Injector - WSJ
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Regeneron and Teva's fasinumab hit with FDA clinical hold | Fierce Biotech
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Teva Pharmaceuticals and MedinCell gain FDA approval for UZEDY, the first subcutaneous, long-acting formulation of risperidone for the treatment of schizophrenia in adults.
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva wins FDA nod for once-daily Austedo (NYSE:TEVA) | Seeking Alpha
Teva's troubled Godollo plant earns firm US FDA warning letter
Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy | Fierce Pharma
Israeli Tech and Innovation News - NoCamels
FDA warns of Adderall shortage after Teva manufacturing delay - YouTube
The Latest Breaking News from Teva Pharmaceutical Industries Ltd – inkl news
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Teva Pharmaceuticals gets FDA approval for Osteoporosis injection | Eric A. Hughes, MD, PhD posted on the topic | LinkedIn
